Abstract：Objective: To analyze the changes of serum Vaspin and MCP-1 levels in patients with coronary heart disease and their correlation with the degree of myocardial injury and cardiac function. Methods: 120 patients with coronary heart disease admitted to our hospital from July 2017 to September 2019 were studied. According to the types of disease, they were divided into unstable angina group (71 cases) and stable angina group (49 cases). According to plaque stability, they were divided into unstable plaque group (53 cases) and stable plaque group (67 cases). According to the number of pathological changes, they were divided into single-vessel disease group (57 cases), double-vessel disease group (38 cases), and triple-vessel disease group (25 cases). In addition, 94 healthy controls in the same period were included. The serum Vaspin and MCP-1 levels were detected by enzyme linked immunosorbent assay. The differences of serum Vaspin and MCP-1 levels, myocardial injury markers and cardiac function parameters between the two groups were compared. The differences of serum Vaspin and MCP-1 levels were compared. The correlation of serum Vaspin and MCP-1 levels with myocardial injury index and cardiac function parameters in patients with coronary heart disease was analyzed. Results: The serum Vaspin level of coronary heart disease group was significantly lower than that of the control group (P<0.05), and the MCP-1 level was significantly higher than that of the control group (P<0.05). The levels of CK-MB, CK, H-FABP and cTnI in the coronary heart disease group were significantly higher than those in the control group (P<0.05). LVEF and FS in coronary heart disease group were significantly lower than those in control group (P<0.05), LVEDD and LVESD were significantly higher than those in control group (P<0.05). The serum Vaspin level in the unstable angina group was significantly lower than that in the stable angina group (P<0.05), and the MCP-1 level was significantly higher than that in the stable angina group (P<0.05). The serum Vaspin level in the unstable plaque group was significantly lower than that in the stable plaque group (P<0.05), and the MCP-1 level was significantly higher than that in the stable plaque group (P<0.05). The levels of serum Vaspin and MCP-1 were significantly higher in ripplee- vessel disease group and double-vessel disease group than in single-vessel disease group (P<0.05). The serum Vaspin level in the triple-vessel disease group was significantly lower than that in the double-vessel disease group (P<0.05), and the MCP-1 level was significantly higher than that in the double-vessel disease group (P<0.05). Serum Vaspin level was positively correlated with LVEF and FS (P<0.05), and negatively correlated with CK-MB, CK, H-FABP, cTnI, LVEDD and LVESD (P<0.05). Serum MCP-1 level was positively correlated with CK-MB, CK, H-FABP, cTnI, LVEDD and LVESD (P<0.05), and negatively correlated with LVEF and FS (P<0.05). Conclusion: The levels of serum Vaspin and MCP-1 in patients with coronary heart disease are closely related with the degree of myocardial injury and cardiac function.
蒋宾, 曹莉梅, 董能斌, 张玲娜. 冠心病患者血清Vaspin和MCP-1水平变化及与患者心肌损伤程度及心功能的相关性分析[J]. 河北医学, 2020, 26(12): 1986-1990.
JIANG Bin, CAO Limei, DONG Nengbin, et al. Changes of Serum Vaspin and MCP-1 Levels in Patients with Coronary Heart Disease and Their Correlation with Myocardial Injury and Cardiac Function. HeBei Med, 2020, 26(12): 1986-1990.
[1] Norfidah Mohamad, Norzulaikha Darul Ikhsan, Raja Anis Raja Ismail, et al. The effect of health education program on knowledge of coronary heart disease (CHD) among public in puncak alam, selangor[J]. Advanced Science Letters, 2018, 24(12):556~558. [2] Paul C Cremer. Compounding uncertainties with first-line computed tomography coronary angiography[J]. Heart, 2018, 104(11):880~883. [3] Jia Peng Bao, Lang Hai Xu, Ji Sheng Ran, et al. Vaspin prevents leptin-induced inflammation and catabolism by inhibiting the activation of nuclear factor-κB in rat chondrocytes[J]. Molecular Medicine Reports, 2017, 16(3):2925. [4] 黄孝宇.单核细胞趋化蛋白-1细胞间黏附分子-1及核转录因子-kappa在人颅内动脉瘤中的表达及临床意义[J].中国实用神经疾病杂志,2019,27(10):1074~1080. [5] Yuan Tian, Ying Yuan, Hang Lu, et al. Analysis of anomalous origin of coronary arteries by coronary angiography in Chinese patients with coronary artery disease[J]. International Journal of Cardiovascular Imaging, 2018, 34(9):1~7. [6] 毕嘉琛,刘志刚,刘晓程.冠状动脉粥样硬化性心脏病的自身免疫机制[J].免疫学杂志,2017,4(5):448~451. [7] H. S. AktaS, Y. E. Uzun, O. Kutlu, et al. The effects of high intensity-interval training on vaspin, adiponectin and leptin levels in women with polycystic ovary syndrome[J]. Archives of Physiology and Biochemistry, 2019, 28(2):1~6. [8] 徐春红,沈丽萍.血清内脏脂肪型丝氨酸蛋白酶抑制剂、不规则趋化因子水平变化与冠心病心绞痛患者心功能的关联性及临床意义探讨[J].中国实验诊断学,2018,22(10):21~25. [9] Junbing He, Yuhua Chen, Yao Lin, et al. Association study of MCP-1 promoter polymorphisms with the susceptibility and progression of sepsis[J]. Plos One, 2017, 12(5):e0176781. [10] 周晓艳,徐艳丽,牛安林,等.急性前循环梗死患者血清中单核细胞趋化蛋白1和血管内皮细胞钙黏蛋白水平变化及其临床意义[J].新乡医学院学报,2018,15(11):1026~1029. [11] 韩艳,臧营,高传玉,等.单核细胞趋化蛋白1肿瘤坏死因子α与冠状动脉斑块易损性的相关性研究[J].重庆医学,2018,47(19):327~330. [12] Kengo S, Remina S, Maho Y, et al. Anti-atherogenic effects of vaspin on human aortic smooth muscle cell/macrophage responses and hyperlipidemic mouse plaque phenotype[J]. International Journal of Molecular Sciences, 2018, 19(6):1732. [13] Gevorgyan, M. M, Voronina, N. P, Goncharova, N. V, et al. Cystatin C as a marker of progressing cardiovascular events during coronary heart disease[J]. Bulletin of Experimental Biology & Medicine, 2017, 162(4):421~424. [14] Wirtwein M, Melander O, SiGren M, et al. Elevated ambulatory systolic-diastolic pressure regression index is genetically determined in hypertensive patients with coronary heart disease[J]. Blood Pressure, 2017, 26(3):174~180. [15] 陈曦,邓蔷,安娜,等.血清Fractalkine、Vaspin含量对冠心病病情的判断价值及其与心功能、心肌损伤程度的相关关系[J].海南医学院学报,2017,23(19):2612~2615.
2020, Vol. 26 
冀公网安备13080202000677号